Arkolith/Insider Trading/NBSE/Form 4

Branning Todd P.

Chief Financial OfficerNeuBase Therapeutics, Inc. (NBSE) · full profile →Form 4 · filed Mar 21, 2022
Net Buying
Open-Market Buys
$18K
Open-Market Sells
$0
Net Open-Market Flow
$18K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 18, 2022Buy(P)10K$1.81$18K30K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-22-036105) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML